Susceptibility to respiratory virus infections (RVIs) varies widely across individuals. Because the gut microbiome impacts immune function, we investigated the influence of intestinal microbiota composition on RVI and determined that segmented filamentous bacteria (SFB), naturally acquired or exogenously administered, protected mice against influenza virus (IAV) infection. Such protection, which also applied to respiratory syncytial virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was independent of interferon and adaptive immunity but required basally resident alveolar macrophages (AMs). In SFB-negative mice, AMs were quickly depleted as RVI progressed. In contrast, AMs from SFB-colonized mice were intrinsically altered to resist IAV-induced depletion and inflammatory signaling. Yet, AMs from SFB-colonized mice were not quiescent. Rather, they directly disabled IAV via enhanced complement production and phagocytosis. Accordingly, transfer of SFB-transformed AMs into SFB-free hosts recapitulated SFB-mediated protection against IAV. These findings uncover complex interactions that mechanistically link the intestinal microbiota with AM functionality and RVI severity.
Pubmed ID: 38295788 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets CD326
View all literature mentionsThis unknown targets C1QA
View all literature mentionsThis monoclonal targets CD31
View all literature mentionsThis monoclonal targets Podoplanin
View all literature mentionsThis monoclonal targets CD45.1
View all literature mentionsThis monoclonal targets CD200
View all literature mentionsThis monoclonal targets CD86
View all literature mentionsThis monoclonal targets FceR1 alpha
View all literature mentionsThis monoclonal targets Siglec-F
View all literature mentionsThis monoclonal targets CD117
View all literature mentionsThis monoclonal targets CD24
View all literature mentionsThis monoclonal targets CD64
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets Ly-6C
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsMus musculus with name Tac:SW from IMSR.
View all literature mentions
Mus musculus with name NOD.Cg-Rag1tm1Mom Il2rg
Mus musculus with name B6(Cg)-C1qatm1d(EUCOMM)Wtsi/TennJ from IMSR.
View all literature mentionsMus musculus with name B6.129S(Cg)-Stat1tm1Dlv/J from IMSR.
View all literature mentionsMus musculus with name B6.129S7-Rag1tm1Mom/J from IMSR.
View all literature mentionsMus musculus with name B6.129S-Csf2tm1Mlg/J from IMSR.
View all literature mentionsMus musculus with name B6.129S(C)-Batf3tm1Kmm/J from IMSR.
View all literature mentionsMus musculus with name C57BL/6J from IMSR.
View all literature mentionsMus musculus with name B6.129S2-Ifnar1tm1Agt/Mmjax from MMRRC.
View all literature mentions